FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
28 mars 2024 09h31 HE
|
Fibrobiologics, Inc.
HOUSTON, March 28, 2024 (GLOBE NEWSWIRE) -- FibroBiologics (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the...